Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial

• Main Authors: Gaëlle Beal (Author), Catherine Barbier (Author), Sophie Thoret (Author), Amandine Rubio (Author), Mathilde Bonnet (Author), Roseline Mazet (Author), Anne Ego (Author), Isabelle Pin (Author)
• Format: Book
• Published: BMC, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The use and optimal duration of treatment with nebulized hypertonic saline (HS) in infants hospitalized for acute bronchiolitis is unclear. The objective was to compare the efficacy of 1 versus 3 days of nebulized 3% HS at 72 h of treatment. We conducted a blinded non-inferiority...